Web Images Videos Maps News Shopping Gmail more »
Sign in 
Go to Google News Home 
  Advanced archive search
  Archive search help
 News Archives   News Articles - Timeline   Results 1 - 10 of about 137 for diovan + reduce + cardiovascular. (0.20 seconds) 
« View recent news results for diovan reduce cardiovascular
2005  Search other dates

Health Canada Approves Diovan (valsartan) to reduce cardiovascular...
Medical News Today - Medical News Today (press release) - Sep 26, 2005
 The Health Canada approval of Diovan* to reduce cardiovascular death in high-risk heart attack survivors is based on the results of VALIANT, ...
Related web pages

… Approves Diovan(R) (Valsartan) to Reduce Cardiovascular Death in...
$4.95 - PR Newswire - ECNext - Aug 3, 2005
 The FDA approval of Diovan to reduce cardiovascular death in high-risk heart attack survivors is based on the results of VALIANT, one of the largest, ...
Related web pages

PR Newswire | Online Press Releases | Highbeam Research – Free Trial
Pay-Per-View - PR Newswire - HighBeam Research - Aug 3, 2005
 The FDA approval of Diovan to reduce cardiovascular death in high-risk heart attack survivors is based on the results of VALIANT, one of the largest, ...
Related web pages

Novartis' Diovan OK'd for a new use.(FDA approves Diovan)
Free with registration - Chain Drug Review - AccessMyLibrary.com - Aug 29, 2005
 The FDA's approval of Diovan to reduce cardiovascular death in high-risk heart attack survivors is based on a landmark trial involving more than 14000 ...
Novartis gets FDA approval for heart attack... - Entrepreneur
All 2 related - Related web pages

Novartis gets broader FDA indication, for heart failure, on Diovan.
Pay-Per-View - Pharma Marketletter - Factiva, from Dow Jones - Aug 15, 2005
 All the approvals of Diovan to reduce cardiovascular death in high-risk heart attack survivors were based on the results of VALIANT, says Novartis, ...
Related web pages

PR Newswire | Online Press Releases | Highbeam Research – Free Trial
Pay-Per-View - PR Newswire - HighBeam Research - Aug 3, 2005
 BACKGROUND: The FDA has just approved Diovan(R) (valsartan) to reduce cardiovascular death in patients at high risk following a heart attack. ...
Related web pages

Diovan(R) receives EU approval for the treatment of heart attack...
Medical News Today - Medical News Today (press release) - May 9, 2005
 ... physicians can now prescribe Diovan to help reduce mortality in patients who have ... Diovan is the only cardiovascular agent ever demonstrated by a ...
Novartis' Diovan receives EU approval for... - Forbes
All 2 related - Related web pages

Diovan gains new indication plus expanded labeling.(LATEBREAKERS)
Free with registration - Drug Topics - AccessMyLibrary.com - Aug 22, 2005
 Novartis' angiotensin receptor blocker, Diovan (valsartan), has been granted approval to reduce cardiovascular mortality in post-myocardial infarction ...
Related web pages

FDA Approves New Post-Heart Attack Treatment.
$4.95 - PR Newswire - ECNext - Aug 3, 2005
 BACKGROUND: The FDA has just approved Diovan(R) (valsartan) to reduce cardiovascular death in patients at high risk following a heart attack. ...
Related web pages

FDA approves Diovan.(PHARMACY NEWS)(Food and Drug Administration)( …
Free with registration - MMR - AccessMyLibrary.com - Aug 22, 2005
 ... Administration has approved Diovan (valsartan) for a new indication to reduce cardiovascular death in patients at high risk following a heart attack. ...
Related web pages






Dates associated with search results are estimated and are determined automatically by a computer program.
 

Google Home - About Google - About News archive search

©2009 Google